Facts
Facts:
Year end revenues > $125mil
Year end EBIT $25mil
Australian GMP granted
Shipments to Australia occurred
$9mil from Hexo being litigated (and if you think they won't get anything, you're dreaming)
The financials are strong and will get stronger. They are executing their global plan to perfection and only need EU GMP to open the German market (with already strong partner in pocket).
Like most companies in the space, the Canadian rollout hampered them a bit and COVID will put a damper on things, but vices always sell (even in down times, like the article posted earlier suggests), so do you think more or less people are going to hit the anti-anxiety CBD oil?
Boggles my mind why the price is heading lower today, if anything it should hold steady and maybe even head a bit higher to the next plateau.